0001567619-20-005036.txt : 20200227
0001567619-20-005036.hdr.sgml : 20200227
20200227173313
ACCESSION NUMBER: 0001567619-20-005036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200225
FILED AS OF DATE: 20200227
DATE AS OF CHANGE: 20200227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rousseau Raphael
CENTRAL INDEX KEY: 0001754287
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38663
FILM NUMBER: 20664059
MAIL ADDRESS:
STREET 1: C/O GRITSTONE ONCOLOGY, INC.
STREET 2: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gritstone Oncology, Inc.
CENTRAL INDEX KEY: 0001656634
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: (510) 871-6100
MAIL ADDRESS:
STREET 1: 5858 HORTON STREET, SUITE 210
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
4
1
doc1.xml
FORM 4
X0306
4
2020-02-25
0
0001656634
Gritstone Oncology, Inc.
GRTS
0001754287
Rousseau Raphael
C/O GRITSTONE ONCOLOGY, INC.
5959 HORTON STREET, SUITE 300
EMERYVILLE
CA
94608
0
1
0
0
See Remarks
Stock Option (Right to Buy)
8.91
2020-02-25
4
A
0
110000
0
A
2020-04-01
2030-02-24
Common Stock
110000
110000
D
The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on March 1, 2020.
Executive Vice President and Chief Medical Officer
/s/ Jean-Marc Bellemin, Attorney-in-Fact for Raphael Rousseau
2020-02-27